Plecanatide
GC-C agonist for CIC and IBS-C treatment. Structurally related to uroguanylin with enhanced GC-C receptor selectivity, providing effective bowel regularity with minimal side effects.
Our Plecanatide API (CAS:467426-54-6) is a guanylate cyclase C (GC-C) agonist peptide, dedicated to scientific research and pharmaceutical R&D related to chronic idiopathic constipation and irritable bowel syndrome, with stable supply, global fast delivery and professional service, suitable for global foreign trade procurement needs.
| Parameter | Specification |
| CAS | 467426-54-6 |
| Molecular Formula | C₆₅H₈₃N₁₅O₂₁S₆ |
| Molecular Weight | 1681.82 g/mol |
| Category | GI Motility |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | CIC, IBS-C, functional bowel disorders, opioid-induced constipation |
| CAS | 467426-54-6 |
|---|---|
| Applications | Chronic Idiopathic Constipation, GI Motility Disorders, IBS-C |
Related products
-
Exenatide Acetate
CAS: 141732-76-5Applications: GLP-1, obesity management, Type 2 diabetes -
Lixisenatide
CAS: 320367-13-3Applications: postprandial glucose control, Short-acting GLP-1, Type 2 diabetes -
Teduglutide
CAS: 197922-42-2Applications: Crohn Disease, GLP-2, Intestinal Repair, Short Bowel Syndrome -
Mazdutide
CAS: 2259884-03-0Applications: metabolic syndrome, Overweight treatment, Type 2 diabetes